Al Altomari, Chairman and CEO
Agile Therapeutics
Charlene Banard, Global Head of Technical Operations Cell & Gene Therapy Strategy, Innovation Pipeline and PMO
Novartis
Jeffrey Berkowitz, Board Member
H. Lundbeck A/S
Liz Bywater, Ph.D., President
Bywater Consulting Group
Ron Cohen, M.D., President & CEO
Acorda Therapeutics
Laurie Cooke, former CEO
Healthcare Businesswomen's Association (HBA)
John Crowley, Chairman and CEO
Amicus Therapeutics
Rich Daly, Chief Operating Officer
Beyond Spring
Raúl Díaz, Animal Health Large Molecules Biopharm. Operations
MSD, Montes Claros, MG, Brazil
Tom Dilenge, President, Advocacy, Law & Public Policy Division
Biotechnology Innovation Organization
Joseph Ferra, CFO
Elevation Oncology
Anu Hans, VP, Strategic Initiatives
Janssen Supply Chain
Fred Hassan, Managing Director
Warburg Pincus
Paul Hastings, President and CEO
Nkarta Therapeutics
Axel Hoos, M.D., Ph.D., CEO
Scorpion Therapeutics
John Hubbard, Ph.D., Emeritus Editorial Advisory Board Member
Life Science Leader
Mitchell Katz, Ph.D., Vice President, Development Operations
Ferring Pharmaceutical, Inc.
Mary Rose Keller, VP, Head Of Clinical Operations
Acrivon Therapeutics
Rachel King, CEO
GlycoMimetics
Suresh Kumar, Former EVP External Affairs
Sanofi
John LaMattina, Ph.D., Sr. Partner
PureTech Health
Jacks Lee, SVP Global Manufacturing and Supply
Merck
Martin Lehr, CEO
Context Therapeutics
Sandy Macrae, Ph.D., President & CEO
Sangamo Therapeutics
Ken Moch, Former President & CEO
Cognition Therapeutics
Carol Nacy, Ph.D., CEO
Sequella
Francois Nader, M.D., Chairman of the Board
Acceleron Pharma
Sandra E. Poole, Chief Operating Officer
Mythic Therapeutics
Dennis Purcell, Founder & Sr. Advisor
Aisling Capital
David Pyott, Chairman of the Board
Bioniz Therapeutics
Chandra Ramanathan, Ph.D., MBA, VP & Head, East Coast Innovation Center
Bayer
Stephen Rapundalo, Ph.D., President & CEO
MichBio
Pamela Reilly Contag, Ph.D., Cofounder and CEO
BioEclipse Therapeutics
John Reynders, Ph.D., VP, R&D Strategy, Program Management, and Data Sciences
Alexion
James Robinson, Emeritus Editorial Advisory Board Member
Life Science Leader
Tomasz Sablinski, M.D., Ph.D., Managing Director, Head of Clinical Development
Auven Therapeutics
Jim Scibetta, CEO
Maverick Therapeutics
Chhaya Shah, SVP Technical Operations
Radius Health
Allan Shaw, Independent Consultant
Brandi Simpson, VP Business and Corporate Development
Voyager Therapeutics
Andrew Skibo, Emeritus Editorial Advisory Board Member, Life Science Leader
MedImmune / AstraZeneca
Jason Urban, Ph.D., Sr. Dir. Quality Risk Management
Alexion
Thomas Wiggans, Founder, CEO, Chairman
Dermira
Leslie Williams, Entrepreneur, Executive, Board Member, Mentor
Tim Wright, CEO
MiMedx

ASK THE BOARD

More From Ask The Board

IN THIS MONTH'S ISSUE

  • Companies To Watch: AltruBio
    9/1/2021

    : AltruBio’s new approach — regulating a checkpoint to mediate T cells in immune diseases — can surprise people more familiar with checkpoint-blocking cancer treatments now on the market.
  • Genesis Of A Gene Therapy Manufacturing Giant
    9/1/2021

    Dr. Timothy Miller is trying to build one of the world’s largest AAV gene therapy manufacturing facilities. The cofounder and CEO of Columbus, OH-based Forge Biologics has been scratching the regenerative medicine leadership itch for quite a while now.
  • VCs Breathe New Life Into Life Sciences Industrials
    9/1/2021

    The “industrials” or supplier sector of the biopharma industry, in a significant change from the past, is now receiving an extra financial boost from VC funding. Why should their biopharma customers care?
  • Creating A Culture of Innovation In Any Size Organization
    9/1/2021

    A company’s size and culture play a large role in how it defines and executes innovation.
More From Current Issue

BEYOND THE PRINTED PAGE

More From Beyond The Printed Page

@LIFESCILEADER1

 EVENTS